ロード中...
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells
The present studies were designed to determine whether the multi-kinase inhibitor sorafenib (Nexavar) interacted with histone deacetylase inhibitors to kill glioblastoma and medulloblastoma cells. In a dose-dependent fashion sorafenib lethality was enhanced in multiple genetically disparate primary...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3679096/ https://ncbi.nlm.nih.gov/pubmed/22406992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.19771 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|